Dyadic International DYAI
NASDAQ DYAI
$0.51 0.00 (-0.31%)
As of: Sep 10, 2026 · 1:27 PM EDT

Dyadic International (DYAI) Other Working Capital Changes (2018 - 2026)

Dyadic International's (DYAI) quarterly Other Working Capital Changes came in at -$44908.0 in Q1 2026, up 51.29% year-over-year from -$29682.6 in Q1 2025, and up 62.85% quarter-over-quarter from -$120880.0 in Q4 2025.

Analysis

Dyadic International (DYAI) Other Working Capital Changes (2018 - 2026) Analysis & Trends

Dyadic International has disclosed Other Working Capital Changes across 9 years of filings, most recently posting -$44908.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 51.29% year-over-year to -$44908.0; the TTM figure through Mar 2026 stood at -$36670.0 (down 17.21% YoY), while the FY2025 annual figure was -$83964.0, down 239.36% from the prior year.
  • Other Working Capital Changes came in at -$44908.0 for Q1 2026 at Dyadic International, up from -$120880.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q2 2025 to a low of -$620282.0 in Q1 2026.
  • Average Other Working Capital Changes over 5 years is $56436.6, with a median of $24464.0 recorded in 2023.
  • The largest YoY upside for Other Working Capital Changes was 104.3% in 2023 against a maximum downside of 907.5% in 2023.
  • Over 5 years, Other Working Capital Changes stood at -$44117.0 in 2022, then tumbled by 907.5% to -$444479.0 in 2023, then soared by 84.0% to -$71128.0 in 2024, then tumbled by 69.95% to -$120880.0 in 2025, then soared by 62.85% to -$44908.0 in 2026.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$44908.0 in Q1 2026, -$120880.0 in Q4 2025, and $254966.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.38 Bn 192.39 Bn 7.24 Bn
2 Gilead Sciences 180.22 Bn 177.04 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.28 Bn 123.42 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.96 Bn 73.97 Bn 3.93 Bn
5 Argenx Se 60.49 Bn 55.30 Bn 1.37 Bn
6 Moderna 53.90 Bn 48.76 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.41 Bn 30.11 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 29.08 Bn 29.08 Bn 1.16 Mn
10 Dyadic International 18.44 Mn 10.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -620,282.00
Mar 31, 2026 -620,282.00
Dec 31, 2025 393,714.00
Dec 31, 2025 393,714.00
Sep 30, 2025 -496,393.00
Sep 30, 2025 -496,393.00
Jun 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 -168,597.00
Mar 31, 2025 -168,597.00
Dec 31, 2024 319,330.00
Dec 31, 2024 319,330.00
Sep 30, 2024 32,160.00
Sep 30, 2024 32,160.00
Jun 30, 2024 -51,695.00
Jun 30, 2024 -51,695.00
Mar 31, 2024 43,905.00
Mar 31, 2024 43,905.00
Dec 31, 2023 581,723.00
Dec 31, 2023 581,723.00